Skip to main content
Default Image

Unjust Cause: Historian Gar Alperovitz on the decision to bomb Hiroshima and Nagasaki

In this conversation with journalist Andrew Cockburn, our co-founder Gar Alperovitz, author of The Decision to Use the Atomic Bomb and the Architecture of An American Myth, discusses the use of the atomic bomb in light of President Obama’s recent trip to Japan:

Here’s what I think happened. Not knowing whether the bomb would work or not, the top U.S. leaders were advised early on that the Russian declaration of war, combined with assurances that the emperor could stay on in some titular role without power, would end the war. That’s why at Yalta [the February 1945 summit between Roosevelt, Stalin, and Churchill] we desperately begged the Russians to come in, and they agreed to come in three months after the German war ended.

U.S. intelligence early on had said this would end the war, which is why we sought their involvement before the bomb was tested. After the bomb was tested, the United States was desperately trying to get the war over before they came in… Read full article.

Publication date: 2016-05-24
Parent publication: Harper's Magazine
Publication URL: http://harpers.org/blog/2016/05/unjust-cause/

More related work

March 19, 2020
Default Image

Protect the vulnerable, advance the democratic economy: Our statement on the COVID-19 crisis

We are in a period of breakdown, in which all that is wrong with the current system is now being laid bare. Rather than rebuild what we now clearly see should never have been, we must lead the construction out of this crisis of something new.

read more
March 18, 2020
Default Image

HAN Public Comments on Fair Housing Act Proposed Changes

The Healthcare Anchor Network submitted public comments to the Department of Housing and Urban Development (HUD), expressing our opposition to HUD’s proposed changes to the 2015 Affirmatively Furthering Fair Housing rule.

read more
March 17, 2020
An array of prescription medications on shelves

Online press briefing: Vaccines—The COVID-19 Case for Public Pharmaceutical Research and Development

Leading experts believe that it is the government’s responsibility to ensure widespread access to safe and effective vaccines that are developed with taxpayer money. In this virtual press briefing, hear why the U.S. government should develop and manufacture vaccines and other essential medicines so that we get the medicines we need, when we need them and at prices we can afford.

read more